𝔖 Bobbio Scriptorium
✦   LIBER   ✦

?Real life? use of sirolimus-eluting coronary stents in Germany

✍ Scribed by Zahn, R. ;Hamm, C. W. ;Zeymer, U. ;Schneider, S. ;Nienaber, C. A. ;Richardt, G. ;Kelm, M. ;Levenson, B. ;Bonzel, T. ;Tebbe, U. ;Sch�bel, W. A. ;Sabin, G. ;Senges, J.

Publisher
Springer
Year
2004
Tongue
German
Weight
305 KB
Volume
93
Category
Article
ISSN
0300-5860

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of sirolimus-eluting stent, p
Comparison of sirolimus-eluting stent, paclitaxel-eluting stent, and bare metal stent in the treatment of long coronary lesions
✍ Young-Hak Kim; Seong-Wook Park; Cheol Whan Lee; Myeong-Ki Hong; Hyeon-Cheol Gwon 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 2 views

## Abstract Objective: This study compared the efficacy of the sirolimus‐eluting stent (SES), the paclitaxel‐eluting stent (PES), and the bare metal stent (BMS) for long coronary lesions. Background: The outcome of drug‐eluting stent (DES) implantation in long coronary lesions remains unclear. Meth

Selective versus exclusive use of siroli
Selective versus exclusive use of sirolimus-eluting stent implantation in multivessel coronary artery disease
✍ William W. Chu; Seung-Woon Rha; Pramod K. Kuchulakanti; Edouard Cheneau; Rebecca 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB 👁 2 views

Sirolimus-eluting stents (SESs; Cypher) have demonstrated a significant reduction in restenosis rates when compared to bare metal stents (BMSs). The purpose of this study was to evaluate the strategy of exclusive use of two SESs versus the combination of one BMS and one SES for two-vessel coronary a